Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study
The Lancet Neurology
Fecha de publicación: 13 September 2019
Autores: Ingrid S van Maurik, MSc., Stephanie J Vos, PhD., Isabelle Bos, PhD., Femke H Bouwman, MD., Prof Charlotte E Teunissen, PhD
Prof Philip Scheltens, MD., et al.
Background: Biomarker-based risk predictions of dementia in people with mild cognitive impairment are highly relevant for care planning and to select patients for treatment when disease-modifying drugs become available. We aimed to establish robust prediction models of disease progression in people at risk of dementia.